BRCA1 and breast carcinoma: BRCA1 (Breast cancer antigen 1) or BRCA2 (Breast cancer antigen 2) mutations confer the women with a 50–80% lifetime risk of breast cancer and 16–65% lifetime risk of ovarian cancer.